Skip to contentM
Marimed Inc.
M
MRMDMarimed Inc. Q3 2020 · 10-Q
Revenue$13.46M$13.46M+219.8% vs Q3 2019 Net Income$1.66M$1.66MN/M vs Q3 2019 EPS Diluted$0.00$0.00N/M vs Q3 2019 Gross Profit$8,679,827+84.7% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Marimed Inc. · CIK 1522767 · Engraved from SEC EDGAR
Operating Cash Flowderived$1,066,353N/M Free Cash Flowderived-$329,045N/M Margins · derivedGross margin64.5%−47.2 pt vs Q3 2019
Operating margin25.2%+2.1 pt vs Q3 2019
Net margin12.3%+188.1 pt vs Q3 2019
ended Sep 30, 2020 · filed Nov 9, 2020 · 40 d after period end